Authors:
Louhimo, J
Nordling, S
Alfthan, H
von Boguslawski, K
Stenman, UH
Haglund, C
Citation: J. Louhimo et al., Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies, HISTOPATHOL, 38(5), 2001, pp. 418-424
Authors:
Leivonen, M
Nordling, S
Lundin, J
von Boguslawski, K
Haglund, C
Citation: M. Leivonen et al., p27 expression correlates with short-term, but not with long-term prognosis in breast cancer, BREAST CANC, 67(1), 2001, pp. 15-22
Authors:
Salmenkivi, K
Haglund, C
Arola, J
Heikkila, P
Citation: K. Salmenkivi et al., Increased expression of tenascin in pheochromocytomas correlates with malignancy, AM J SURG P, 25(11), 2001, pp. 1419-1423
Authors:
Hedstrom, J
Haglund, C
Leinonen, J
Nordling, S
Stenman, UH
Citation: J. Hedstrom et al., Trypsinogen-1,-2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas, SC J CL INV, 61(2), 2001, pp. 111-118
Authors:
Wiksten, JP
Lundin, J
Nordling, S
Lundin, M
Kokkola, A
von Bocuslawski, K
Haglund, C
Citation: Jp. Wiksten et al., Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer, INT J CANC, 95(1), 2001, pp. 1-6
Authors:
Lundin, M
Nordling, S
Lundin, J
Alfthan, H
Stenman, UH
Haglund, C
Citation: M. Lundin et al., Tissue expression of human chorionic gonadotropin beta predicts outcome incolorectal cancer: A comparison with serum expression, INT J CANC, 95(1), 2001, pp. 18-22
Authors:
Paju, A
Sorsa, T
Tervahartiala, T
Koivunen, E
Haglund, C
Leminen, A
Wahlstrom, T
Salo, T
Stenman, UH
Citation: A. Paju et al., The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation, BR J CANC, 84(10), 2001, pp. 1363-1371
Authors:
Hemmer, S
Wasenius, VM
Haglund, C
Zhu, Y
Knuutila, S
Franssila, K
Joensuu, H
Citation: S. Hemmer et al., Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations inparathyroid adenomas, AM J PATH, 158(4), 2001, pp. 1355-1362
Authors:
Ristimaki, A
Nieminen, O
Saukkonen, K
Hotakainen, K
Nordling, S
Haglund, C
Citation: A. Ristimaki et al., Expression of cyclooxygenase-2 in human transitional cell carcinoma of theurinary bladder, AM J PATH, 158(3), 2001, pp. 849-853
Citation: J. Siren et al., An institutional experience with 40 first lateral transperitoneal laparoscopic adrenalectomies, SURG LA E P, 10(6), 2000, pp. 382-386
Authors:
Lundin, M
Nordling, S
Carpelan-Holmstrom, M
Louhimo, J
Alfthan, H
Stenman, UH
Haglund, C
Citation: M. Lundin et al., A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer, ANTICANC R, 20(6D), 2000, pp. 4949-4951
Authors:
Lundin, M
Nordling, S
Roberts, PJ
Lundin, J
Carpelan-Holmstrom, M
von Boguslawsky, K
Haglund, C
Citation: M. Lundin et al., Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis, ONCOL-BASEL, 57(1), 1999, pp. 70-76
Authors:
Hedstrom, J
Grenman, R
Ramsay, H
Finne, P
Lundin, J
Haglund, C
Alfthan, H
Stenman, UH
Citation: J. Hedstrom et al., Concentration of free hCG beta subunit in serum as a prognostic marker forsquamous-cell carcinoma of the oral cavity and oropharynx, INT J CANC, 84(5), 1999, pp. 525-528
Authors:
Hedstrom, J
Haglund, C
Kemppainen, E
Leinimaa, M
Leinonen, J
Stenman, UH
Citation: J. Hedstrom et al., Time-resolved immunofluorometric assay of trypsin-I complexed with alpha(1)-antitrypsin in serum: Increased immunoreactivity in patients with biliarytract cancer, CLIN CHEM, 45(10), 1999, pp. 1768-1773